<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01997801</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH_KEThyRobot</org_study_id>
    <nct_id>NCT01997801</nct_id>
  </id_info>
  <brief_title>Ketamine in Robot-assisted Thyroidectomy</brief_title>
  <acronym>KEThyRobot</acronym>
  <official_title>The Efficacy of Intraoperative Ketamine in Patients Undergoing Robot-assisted Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective double-blinded study, The investigators compared acute postoperative pain
      and rescue analgesic demand during postoperative period after robot thyroidectomy between
      ketamine and placebo groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Robot-assisted endoscopic thyroidectomy has been popularized due to cosmetic advantages.
      Despite small incisions, robot thyroidectomy did not offer satisfactory reduction in
      postoperative pain compared to open thyroidectomy. Ketamine is a non-competitive
      N-methyl-D-aspartate (NMDA) receptor blocker and takes some attractive advantages in terms of
      pain control. When low dose ketamine is perioperatively administrated, opioid sparing effect
      during postoperative period is reported in various surgical procedures such as spine,
      thoracic, and gynecologic surgery. Ketamine's beneficial effect on postoperative pain has not
      been investigated in patients undergoing robot thyroidectomy. The investigators hypothesized
      that perioperative ketamine administration can reduce acute postoperative pain after robot
      thyroidectomy and the incidence of chronic pain hypoesthesia on anterior chest at 3 months
      after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at 24 hour postoperatively</measure>
    <time_frame>at 24 hour postoperatively</time_frame>
    <description>Pain at 24 hour postoperatively will be evaluates using 11 point scale (0:no pain, 10:worst imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at 3, 6, 12, 48 and 72 hour postoperatively</measure>
    <time_frame>at 3, 6, 12, 48 and 72 hour postoperatively</time_frame>
    <description>Pain at 3, 6, 12, 48 and 72 hour postoperatively will be evaluated using 11-point scale 0:no pain, 10:worst imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first analgesics postoperatively</measure>
    <time_frame>At 24 hours postoperatively</time_frame>
    <description>Time from the end of anesthesia till the first analgesic agent will be recorded at 24 hours postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic requirements for 24 hours after surgery</measure>
    <time_frame>at 24 hours postoperatively</time_frame>
    <description>Analgesic requirements for 24 hours after surgery will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain at 3 month after surgery</measure>
    <time_frame>At 3 month after surgery</time_frame>
    <description>Chronic pain at 3 month after surgery will be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Thyroid</condition>
  <condition>Acute Pain</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>C group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In C group, NS infusion will be done intraoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KET group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In KET group, ketamine infusion will be done intraoperatively(0.25 mg/kg bolus injection following 100 mcg/kg/hr till the end of surgery).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine infusion</intervention_name>
    <description>Ketamine will be infused intraoperatively (0.25 mg/kg intravenous bolus following continuous infusion of 100 mcg/kg/hr).</description>
    <arm_group_label>KET group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NS infusion</intervention_name>
    <description>Normal saline will be infused intraoperatively.</description>
    <arm_group_label>C group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for robot-assisted thyroidectomy

          -  ASA I-III

        Exclusion Criteria:

          -  Patients with renal dysfunction

          -  Patients with hepatic dysfunction

          -  Patients with neurologic dysfunction

          -  Patients with the history of drug addiction

          -  Patients with chronic pain

          -  Patients who are allergic to ketamine

          -  Patients with increased ocular or intracranial pressure

          -  Patients with the risk of aspiration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Pyoung Park, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University of Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hee-Pyoung Park, PhD</last_name>
    <phone>+82-10-2971-7647</phone>
    <email>hppark@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hyun-Chang Kim, MD</last_name>
    <phone>+82-10-2886-2876</phone>
    <email>onidori1979@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hee-Pyoung Park, PhD</last_name>
      <phone>+82-10-2971-7647</phone>
      <email>hppark@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Hyun-Chang Kim, MD</last_name>
      <phone>+82-10-2886-2876</phone>
      <email>onidori1979@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Hee-Pyoung Park, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>November 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>November 24, 2013</last_update_submitted>
  <last_update_submitted_qc>November 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Pyoung Park</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Thyroidectomy</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Ketamine</keyword>
  <keyword>Acute Pain</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Postoperative period</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

